A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

Clinical trial NCT02016755 · COMPLETED

Trial details

NCT number: NCT02016755
Sponsor: AnGes USA, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia Vascular Diseases Peripheral Arterial Disease

Start date: 2013-11-01
Primary completion: 2018-03-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.